This early study did not assess TIGIT expression, but more recent studies have shown increased TIGIT expression by NK cells in AML corresponds to a dysfunctional phenotype and poor prognosis (66), suggesting upregulation of the TIGIT-CD155/CD112 axis may be a key mechanism of AML escape from NK cytotoxicity. The gene discussed is PVR; the disease is acute myeloid leukemia.